Peptide Therapeutics Market Size, Share, Trends, Growth Outlook

Peptide Therapeutics Market is estimated to increase at a growth rate of 7.4% CAGR over the forecast period from 2024 to 2030.

The global Peptide Therapeutics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Cancer, Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological Disorders, Renal Disorders, Others), By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, Others), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology).

An introduction to Peptide Therapeutics Market in 2024

Harnessing the therapeutic potential of peptides as molecular tools and pharmaceutical agents, the Peptide Therapeutics Market offers a diverse pipeline of peptide-based drugs and biologics targeting a wide range of diseases and biological targets, including cancer, metabolic disorders, autoimmune diseases, and cardiovascular conditions. Peptide therapeutics encompass peptide hormones, enzyme inhibitors, receptor agonists/antagonists, and vaccine peptides, designed for systemic or targeted delivery via various administration routes such as subcutaneous injection, oral ingestion, or inhalation. The market's growth is driven by advancements in peptide synthesis, formulation, and drug delivery technologies, alongside increasing investment in peptide drug discovery, peptide library screening, and computational peptide design accelerating peptide therapeutics development and commercialization efforts.

Peptide Therapeutics market Trend: Expansion of Peptide Therapeutics Pipeline

A significant trend in the Peptide Therapeutics market is the expansion of the peptide therapeutics pipeline. With advancements in peptide synthesis, modification, and delivery technologies, there's a growing interest in peptides as viable therapeutic agents for addressing a wide range of diseases. Pharmaceutical companies and research institutions are increasingly investing in the discovery and development of novel peptide-based drugs targeting various therapeutic areas, including oncology, metabolic disorders, cardiovascular diseases, and infectious diseases. This trend towards an expanding peptide therapeutics pipeline reflects the versatility and potential of peptides as effective and safe treatments, driving innovation and growth in the peptide therapeutics market.

Peptide Therapeutics market Driver: Increasing Incidence of Chronic and Age-Related Diseases

The primary driver in the Peptide Therapeutics market is the increasing incidence of chronic and age-related diseases. Conditions such as cancer, diabetes, cardiovascular diseases, and neurodegenerative disorders represent significant healthcare challenges globally, contributing to high morbidity and mortality rates. Peptide therapeutics offer several advantages, including high specificity, low toxicity, and favorable pharmacokinetic properties, making them attractive candidates for targeting complex disease pathways and improving treatment outcomes. As the burden of chronic and age-related diseases continues to rise due to aging populations, lifestyle changes, and environmental factors, there's a growing demand for innovative peptide-based therapies that can address unmet medical needs and improve patient care, driving market growth in the peptide therapeutics segment.

Peptide Therapeutics market Opportunity: Development of Peptide-Based Personalized Medicines

One potential opportunity in the Peptide Therapeutics market is the development of peptide-based personalized medicines. With increasing emphasis on precision medicine and personalized healthcare approaches, there's a growing recognition of the importance of tailoring treatments to individual patient characteristics, such as genetic makeup, disease subtype, and biomarker profile. Peptides, with their diverse structures and functionalities, offer potential as versatile platforms for developing personalized medicines that can target specific disease pathways or patient populations. Manufacturers and researchers can capitalize on this opportunity by leveraging advancements in genomics, proteomics, and bioinformatics to identify patient-specific targets and design customized peptide therapies. By offering personalized peptide medicines tailored to patients' unique needs, companies can enhance treatment efficacy, minimize adverse effects, and differentiate themselves in the competitive peptide therapeutics market.

Peptide Therapeutics Market Market Segmentation

By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Peptide Therapeutics Market Companies

Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd

Reasons to Buy the Peptide Therapeutics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Peptide Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Peptide Therapeutics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Peptide Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Peptide Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 Peptide Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Peptide Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Peptide Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Peptide Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Peptide Therapeutics Industry
4.2 Key Market Trends in Peptide Therapeutics Industry
4.3 Potential Opportunities in Peptide Therapeutics Industry
4.4 Key Challenges in Peptide Therapeutics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Peptide Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Peptide Therapeutics Market Outlook by Segments
7.1 Peptide Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

8 North America Peptide Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America Peptide Therapeutics Markets in 2024
8.2 North America Peptide Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Peptide Therapeutics Market size Outlook by Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

9 Europe Peptide Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Peptide Therapeutics Markets in 2024
9.2 Europe Peptide Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Peptide Therapeutics Market Size Outlook by Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

10 Asia Pacific Peptide Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Peptide Therapeutics Markets in 2024
10.2 Asia Pacific Peptide Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Peptide Therapeutics Market size Outlook by Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

11 South America Peptide Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America Peptide Therapeutics Markets in 2024
11.2 South America Peptide Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Peptide Therapeutics Market size Outlook by Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

12 Middle East and Africa Peptide Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Peptide Therapeutics Markets in 2024
12.2 Middle East and Africa Peptide Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Peptide Therapeutics Market size Outlook by Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology